Traws Pharma, Inc.
TRAW • NASDAQ
Traws Pharma, Inc. is a publicly traded company trading on NASDAQ, led by CEO Iain D. Dukes, with a market cap of $14.1M.
CEOIain D. Dukes
Next Earnings
Upcoming earnings announcement for Traws Pharma, Inc.
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.75
Earnings History
Past 8 earnings reports for Traws Pharma, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.34 | — | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.11 | — | $2.7M | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$1.58Est: -$8.04 | +80.3% | $57.0KEst: $60.0K | -5.0% | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$9.72Est: -$9.55 | -1.8% | $56.0KEst: $60.0K | -6.7% | 10-K/A |
| Nov 14, 2024 | Q3 2024 | -$8.81 | — | $57.0K | — | 10-Q |
| Aug 15, 2024 | Q2 2024 | -$121.75 | — | $57.0K | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$6.00 | — | $56.0K | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$5.00 | — | $56.0K | — | 10-K/A |